Medical imaging AI developer MedCognetics has been awarded a patent for its AI technology in mammography by the U.S. Patent and Trademark Office (USPTO).
The patent covers architectural strategies and methodologies for achieving unbiased AI in breast imaging. The company highlighted that this is supported by MedCognetics’ peer-reviewed publications in industry conferences such as RSNA 2023 and the European Society of Radiology (ESR) 2024, as well as a grant from the National Institutes of Health (NIH).
The USPTO patent number for this MedCognetics entry is 11,948,297.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
